Supply Chain/Technology
Discrepancies in FDA clearance, marketing of AI-, ML-enabled medical devices
Editor's Note This study from New York University and NYU Langone Health, New York City, finds discrepancies between the marketing and 510(k) clearance of artificial intelligence (AI)- or machine learning (ML)-enabled medical devices, with some devices being marketed as having capabilities not approved by the Food and Drug Administration (FDA).…
FDA: Class I recall of Medtronic implantable cardioverter, cardiac resynchronization therapy defibrillators
Editor's Note The Food and Drug Administration (FDA), on July 18, identified the recall by Medtronic of its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. Medtronic is recalling all ICDs and CRT-Ds, with glassed feedthroughs that were manufactured after 2017, as…
Can playing Dungeons and Dragons improve mental well-being?
Editor's Note Researchers at the University of South Australia are studying the use of tabletop role-playing games, such as Dungeons and Dragons, to boost confidence and self-esteem in players to improve their mental well-being. The research is part of a collaboration between the University of South Australia and social gaming…
FDA: Class I recall of Draeger Medical’s Oxylog 3000 Plus Emergency and Transport Ventilators
Editor's Note The Food and Drug Administration (FDA), on July 13, identified the recall by Draeger Medical of its Oxylog 3000 Plus Emergency and Transport Ventilators as Class I, the most serious. The recall was initiated because of reports that the ventilator may not automatically switch back to using AC…
FDA: Class I recall of Megadyne’s Mega 2000, Mega Soft reusable patient return electrodes
Editor's Note The Food and Drug Administration (FDA), on July 11, identified the recall by Megadyne of its Mega 2000 and Mega Soft reusable patient return electrodes as Class I, the most serious. The recall was initiated after Megadyne received reports of pediatric and adult patients receiving burn injuries during…
FDA: Class I recall of Arrow Endurance Extended Dwell Peripheral Catheter System
Editor's Note The Food and Drug Administration (FDA), on June 26, identified the recall by Teleflex, and their subsidiary Arrow International, of the Arrow Endurance Extended Dwell Peripheral Catheter System as Class I, the most serious. The recall was initiated because of the risk of catheter separation and leakage. If…
Contract standardization for endo-mechanical supplies saves millions
Takeaways One of the lessons learned when it comes to data was to make sure you do it right the first time. A big drive for standardization was to leverage the distribution center to send excess inventory that some sites had to sites that needed them. Another drive was the…
Pfizer warns FDA of penicillin shortage
Editor's Note Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports. Pfizer cited a combination of factors for the shortage, including…
FDA: Class I recall of Walnut Wearable Smart Thermometers
Editor's Note The Food and Drug Administration, on June 12, identified the recall of the rechargeable Walnut Wearable Smart Thermometer as Class I, the most serious. BearCare, Inc, is recalling the thermometers after receiving reports of skin burns and irritation resulting from use of the device. The company reports five…
FDA letter on supply shortage of nonsterile, single-use pneumatic tourniquet cuffs
Editor's Note In a June 5 letter to healthcare providers, the Food and Drug Administration (FDA) says it is aware of US healthcare facilities and providers experiencing supply constraints of nonsterile, single-use pneumatic tourniquet cuffs. The cuffs are used in elective limb surgeries and in emergency and trauma settings. During…
Free Daily News
- Healthcare employment up in December
- Hospital M&A trends report reveals financial distress, market reorganization
- Study: Patient care experience declined after private equity hospital acquisitions
- Report: Medical student distress rises amid overall healthcare burnout improvement
- Prosthetic insurance coverage disparities persist despite legal protections
- Study: GLP-1 drugs reduce surgical complications in diabetes patients
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit
- Healthcare M&A activity set to rebound in 2025 amid stricter state oversight
- High participation in ASCQR program continues, March deadline for reconsideration requests
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management